Search Results 851-860 of 17027 for pharmacogenetics

  1. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. A Study to Identify and Characterize Neurophysiological Biomarkers for Progression of Neurodegenerative Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Clinical and Imaging Factors Associated with Symptoms in Patients with Severe Aortic Stenosis

    The aim of this study is to reveal differences between symptomatic and asymptomatic severe AS patients matched for anatomic (aortic valve area) and hemodynamic ...

  4. Medical Research & Education - Mayo Clinic News Network

    The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...

  5. A Study to Support Increased Information and Participation in the Decision Making Process for Parents of Children who have Acute Inflammation of the Middle Ear - Mayo Clinic

    A Study to Support Increased Information and Participation in the Decision Making Process for Parents of Children who have Acute Inflammation of the Middle Ear.

  6. Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients with High-Risk Stage III-IV Melanoma that has been Removed by Surgery - Mayo Clinic

    Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

  7. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients - Mayo Clinic

    About this study. This study will test whether immune functions in individual cancer patients can be characterized in a quantitative manner using new ...

  8. Oncology (Medical) - Clinical trials

    The purpose of this study is to evaluate nab-paclitaxel as maintenance therapy after cisplatin-based chemotherapy and surgery in treating patients with ...

  9. Clinical trials - Oncology (Medical)

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures. - Mayo Clinic

    Plastic biliary stents which are a new larger size will remain free of obstructions for a longer period of time than currently used 10 French stents in cancer ...